Sign in

HIV isolated

1983Big moment

Françoise Barré-Sinoussi and Luc Montagnier's team at the Pasteur Institute isolate the retrovirus that causes AIDS.

The story

In 1983 researchers at the Pasteur Institute in Paris, led by Luc Montagnier with Francoise Barre-Sinoussi and Jean-Claude Chermann, isolated a retrovirus from a lymph node of a patient with swollen glands, a possible early sign of AIDS. They reported the discovery in the journal Science in May 1983. The virus, first called LAV and later renamed HIV (human immunodeficiency virus), was the cause of the epidemic that had alarmed doctors since 1981.

AIDS was first described in June 1981, when the U.S. Centers for Disease Control reported unusual cases of pneumonia and other infections in previously healthy young men in Los Angeles, followed within weeks by reports of a rare cancer among men in New York and California. The cases pointed to a collapse of the immune system. Cases appeared among gay men, injection drug users, hemophilia patients and people who had received blood transfusions, which suggested an infectious agent carried in blood and body fluids, but nobody had identified it. The Pasteur team looked for a retrovirus, a kind of virus that copies its RNA into DNA using an enzyme called reverse transcriptase, because retroviruses had recently been linked to some human leukemias.

HIV attacks CD4 T cells, the white blood cells that coordinate the immune response, and so leaves the body open to infections that would normally be harmless. The French isolation led to a bitter priority dispute with Robert Gallo's laboratory at the U.S. National Cancer Institute, which announced its own virus in 1984. The two governments settled in 1987 with shared credit, and in 2008 the Nobel Prize went to Barre-Sinoussi and Montagnier. Identification made a blood test possible in 1985 and the screening of blood donations, and it enabled drug research: AZT was approved in 1987, and combination therapy from 1996 turned HIV from a fatal disease into a manageable one for people with access to treatment. About 40 million people have died of AIDS-related illnesses.

Why it mattered

  • Blood tests from 1985 allowed screening of the blood supply and diagnosis of infected people.
  • AZT, the first HIV drug, was approved in 1987, followed by combination antiretroviral therapy in 1996.
  • Prevention programs and public health campaigns could be built around a known virus and routes of transmission.
  • The epidemic changed how patients, activists and regulators approached drug development and approval.

Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made

Community notes

Loading notes…

Learn more ranked by votes

Documentnobelprize.org
The Nobel Prize in Physiology or Medicine 2008
Editor's pick
BookRandy Shilts
And the Band Played On
Search Open Library
VideoSearch YouTube
discovery of HIV Pasteur Institute
Search YouTube